Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zaleska

Showing results (71-80 of 91) with videos related to

Pageof 10
Sort By:
Acta Tropica|November 5, 1999
Bacteriological studies of blood, tissue fluid, lymph and lymph nodes in patients with acute dermatolymphangioadenitis (DLA) in course of 'filarial' lymphedemaW L Olszewski, S Jamal, G Manokaran, et al.
British Journal of Pharmacology|September 15, 2011
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymeraseF Moroni, A Cozzi, A Chiarugi, et al.
Brain Research|January 22, 2019
In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [<sup>18</sup>F]MNI-659Marie M Svedberg, Katarina Varnäs, Andrea Varrone, et al.
Journal of Medicinal Chemistry|May 4, 2001
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 typeR B Baudy, H Fletcher, J P Yardley, et al.
Veterinary Microbiology|May 27, 2005
Virulence-associated traits in avian Escherichia coli: comparison between isolates from colibacillosis-affected and clinically healthy layer flocksD Vandekerchove, F Vandemaele, C Adriaensen, et al.
Journal of Medicinal Chemistry|February 11, 1998
Design and synthesis of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid (EAA-090), a potent N-methyl-D-aspartate antagonist, via the use of 3-cyclobutene-1,2-dione as an achiral alpha-amino acid bioisostereW A Kinney, M Abou-Gharbia, D T Garrison, et al.
Neuropharmacology|December 15, 2010
The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluidCheryl L Nickerson-Nutter, Debra Goodwin, Marina W H Shen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 21, 2007
Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic strokeGiora Z Feuerstein, Margaret M Zaleska, Michael Krams, et al.
Cellular Signalling|June 24, 2004
Expression of NALP1 in cerebellar granule neurons stimulates apoptosisFeng Liu, C Frederick Lo, Xiaoping Ning, et al.
Neurobiology of Disease|July 9, 2008
Amiloride is neuroprotective in an MPTP model of Parkinson's diseaseRobert L Arias, Mei-Li A Sung, Dmytro Vasylyev, et al.
Pageof 10

Showing results (71-80 of 91) with videos related to

Sort By:
Pageof 10
Acta Tropica|November 5, 1999
Bacteriological studies of blood, tissue fluid, lymph and lymph nodes in patients with acute dermatolymphangioadenitis (DLA) in course of 'filarial' lymphedemaW L Olszewski, S Jamal, G Manokaran, et al.
British Journal of Pharmacology|September 15, 2011
Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymeraseF Moroni, A Cozzi, A Chiarugi, et al.
Brain Research|January 22, 2019
In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [<sup>18</sup>F]MNI-659Marie M Svedberg, Katarina Varnäs, Andrea Varrone, et al.
Journal of Medicinal Chemistry|May 4, 2001
Design, synthesis, SAR, and biological evaluation of highly potent benzimidazole-spaced phosphono-alpha-amino acid competitive NMDA antagonists of the AP-6 typeR B Baudy, H Fletcher, J P Yardley, et al.
Veterinary Microbiology|May 27, 2005
Virulence-associated traits in avian Escherichia coli: comparison between isolates from colibacillosis-affected and clinically healthy layer flocksD Vandekerchove, F Vandemaele, C Adriaensen, et al.
Journal of Medicinal Chemistry|February 11, 1998
Design and synthesis of [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1(7)-en-2-yl)-ethyl]phosphonic acid (EAA-090), a potent N-methyl-D-aspartate antagonist, via the use of 3-cyclobutene-1,2-dione as an achiral alpha-amino acid bioisostereW A Kinney, M Abou-Gharbia, D T Garrison, et al.
Neuropharmacology|December 15, 2010
The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluidCheryl L Nickerson-Nutter, Debra Goodwin, Marina W H Shen, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|June 21, 2007
Missing steps in the STAIR case: a Translational Medicine perspective on the development of NXY-059 for treatment of acute ischemic strokeGiora Z Feuerstein, Margaret M Zaleska, Michael Krams, et al.
Cellular Signalling|June 24, 2004
Expression of NALP1 in cerebellar granule neurons stimulates apoptosisFeng Liu, C Frederick Lo, Xiaoping Ning, et al.
Neurobiology of Disease|July 9, 2008
Amiloride is neuroprotective in an MPTP model of Parkinson's diseaseRobert L Arias, Mei-Li A Sung, Dmytro Vasylyev, et al.
Pageof 10